PRLDPrelude Therapeutics Incorporated
What is the market doing?
Rangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Rangebound, no clear trend. Oversold (RSI 23). Price is −1% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How PRLD is trading
Prelude Therapeutics Incorporated is +169% over the past year while the S&P 500 is +18%: 151 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −1.0%
vs 200-day average · below trend, but not far
- RSI (14)
- 23
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 41%
Below its 52-week high
Details›
- Last close2026-10-08
- $3.88
- 1 monthS&P 500 +1.6%
- −23%
- 1 yearS&P 500 +18%
- +169%
- 5 yearsS&P 500 +86%
- −88%
- vs 50-day average$4.94
- −22%
- 52-week high
- $6.62
- 52-week low
- $1.19
- Annualised volatility
- 158%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $25M
| Year | Return |
|---|---|
| 2026 (year to date) | +34% |
| 2025 | +127% |
| 2024 | −70% |
| 2023 | −29% |
| 2022 | −51% |
| 2021 | −83% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 1 of 6 | −16% |
| Feb | 6 | 2 of 6 | +3.8% |
| Mar | 6 | 4 of 6 | −2.7% |
| Apr | 6 | 3 of 6 | +5.5% |
| May | 6 | 1 of 6 | −11% |
| Jun | 6 | 2 of 6 | +2.2% |
| Jul | 6 | 2 of 6 | +7.4% |
| Aug | 6 | 4 of 6 | +18% |
| Sep | 6 | 1 of 6 | −18% |
| Oct | 7 | 3 of 7 | −15% |
| Nov | 6 | 3 of 6 | +19% |
| Dec | 6 | 4 of 6 | +23% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.